Skip to main content
  • Thematic Review
  • Educational Series on the Specialist Valve Clinic
  • Open access
  • Published:

The central role of the cardiac imager in heart valve disease

Abstract

In this review, we discuss the central role of the imager in the heart team in the successful application of current guidelines for heart valve diseases to daily practice, and for improving patient care through new approaches, new techniques and new strategies for dealing with increasingly complex cases. This is an opportunity to emphasize the importance of having good imagers and the value of continuous learning in a modern heart team. It is essential to employ technological improvements and to appropriately adapt guidelines to the patients we see day to day.

References

  1. Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, Iung B, Lancellotti P, Lansac E, Rodriguez Muñoz D, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. European Heart Journal 2017 2739–2791. https://doi.org/10.1093/eurheartj/ehx391)

    Google Scholar 

  2. Chambers JB, Prendergast B, Iung B, Rosenhek R, Zamorano JL, Pierard LA, Modine T, Falk V, Kappetein AP, Pibarot P, et al. Standards defining a ‘Heart Valve Centre’: ESC Working Group on valvular heart disease and European Association for cardiothoracic surgery viewpoint. European Journal of Cardio-Thoracic Surgery 2017 418–424. https://doi.org/10.1093/ejcts/ezx283)

    Google Scholar 

  3. Bhattacharyya S, Pavitt C, Lloyd G, Chambers JB & British Heart Valve Society. Prevalence and composition of heart valve multi-disciplinary teams within a national health system. International Journal of Cardiology 2014 1120–1121. https://doi.org/10.1016/j.ijcard.2014.08.070)

    Google Scholar 

  4. Steiner JM, Cooper S & Kirkpatrick JN. Palliative care in end-stage valvular heart disease. Heart 2017 1233–1237. https://doi.org/10.1136/heartjnl-2016-310538)

    Google Scholar 

  5. Castano A, Narotsky DL, Hamid N, Khalique OK, Morgenstern R, DeLuca A, Rubin J, Chiuzan C, Nazif T, Vahl T, et al. Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement. European Heart Journal 2017 2879–2887. https://doi.org/10.1093/eurheartj/ehx350)

    Google Scholar 

  6. Vollema EM, Amanullah MR, Ng ACT, van der Bijl P, Prevedello F, Sin YK, Prihadi EA, Marsan NA, Ding ZP, Généreux P, et al. Staging cardiac damage in patients with symptomatic aortic valve stenosis. Journal of the American College of Cardiology 2019 538–549. https://doi.org/10.1016/j.jacc.2019.05.048)

    Google Scholar 

  7. Pibarot P, Sengupta P & Chandrashekhar Y. Imaging is the cornerstone of the management of aortic valve stenosis. JACC: Cardiovascular Imaging 2019 220–223. https://doi.org/10.1016/j.jcmg.2018.12.001)

    Google Scholar 

  8. Pawade T, Sheth T, Guzzetti E, Dweck MR & Clavel MA. Why and how to measure aortic valve calcification in patients with aortic stenosis. JACC: Cardiovascular Imaging 2019 1835–1848. https://doi.org/10.1016/j.jcmg.2019.01.045)

    Google Scholar 

  9. Jain P & Fabbro M 2nd. ACC Expert Consensus Decision pathway on the management of mitral regurgitation: a review of the 2017 document for the cardiac anesthesiologist. Journal of Cardiothoracic and Vascular Anesthesia 2019 274–289. https://doi.org/10.1053/j.jvca.2018.07.029)

    Google Scholar 

  10. Pibarot P, Delgado V & Bax JJ. MITRA FR vs. COAPT: lessons from two trials with diametrically opposed results. European Heart Journal: Cardiovascular Imaging 2019 620–624. https://doi.org/10.1093/ehjci/jez073)

    Google Scholar 

  11. Bertaina M, Galluzzo A, D’Ascenzo F, Conrotto F, Grosso Marra W, Frea S, Alunni G, Crimi G, Moretti C, Montefusco A, et al. Prognostic impact of MitraClip in patients with left ventricular dysfunction and functional mitral valve regurgitation: a comprehensive meta-analysis of RCTs and adjusted observational studies. International Journal of Cardiology 2019 70–76. https://doi.org/10.1016/j.ijcard.2019.05.015)

    Google Scholar 

  12. De Rosa R, Silverio A, Baldi C, Di Maio M, Prota C, Radano I, Rey J, Herrmann E, Citro R, Piscione F, et al. Transcatheter repair of functional mitral regurgitation in heart failure patients–a meta-analysis of 23 studies on MitraClip implantation. Circulation Journal 2018 2800–2810. https://doi.org/10.1253/circj.CJ-18-0571)

    Google Scholar 

  13. Giannini C, D’Ascenzo F, Fiorelli F, Spontoni P, Swaans MJ, Velazquez EJ, Armeni P, Adamo M, De Carlo M & Petronio AS. A meta-analysis of MitraClip combined with medical therapy vs. medical therapy alone for treatment of mitral regurgitation in heart failure patients. ESC Heart Failure 2018 1150–1158. https://doi.org/10.1002/ehf2.12339)

    Google Scholar 

  14. D’Ascenzo F, Moretti C, Marra WG, Montefusco A, Omede P, Taha S, Castagno D, Gaemperli O, Taramasso M, Frea S, et al. Meta-analysis of the usefulness of MitraClip in patients with functional mitral regurgitation. American Journal of Cardiology 2015 325–331. https://doi.org/10.1016/j.amjcard.2015.04.025)

    Google Scholar 

  15. Obadia JF, Messika-Zeitoun D, Leurent G, Iung B, Bonnet G, Piriou N, Lefèvre T, Piot C, Rouleau F, Carrié D, et al. Percutaneous repair or medical treatment for secondary mitral regurgitation. New England Journal of Medicine 2018 2297–2306. https://doi.org/10.1056/NEJMoa1805374)

    Google Scholar 

  16. Stone GW, Lindenfeld J, Abraham WT, Kar S, Lim DS, Mishell JM, Whisenant B, Grayburn PA, Rinaldi M, Kapadia SR, et al. Transcatheter mitral-valve repair in patients with heart failure. New England Journal of Medicine 2018 2307–2318. https://doi.org/10.1056/NEJMoa1806640)

    Google Scholar 

  17. Chambers JB, Prendergast B, Iung B, Rosenhek R, Zamorano JL, Pierard LA, Modine T, Falk V, Kappetein AP, Pibarot P, et al. Standards defining a ‘Heart Valve Centre’: ESC Working Group on valvular heart disease and European Association for cardiothoracic surgery viewpoint. European Heart Journal 2017 2177–2183. https://doi.org/10.1093/eurheartj/ehx370)

    Google Scholar 

  18. David TE, David CM, Tsang W, Lafreniere-Roula M & Manlhiot C. Long-term results of mitral valve repair for regurgitation due to leaflet prolapse. Journal of the American College of Cardiology 2019 1044–1053. https://doi.org/10.1016/j.jacc.2019.06.052)

    Google Scholar 

  19. Gafoor S & Wang DD. Does the idea of percutaneous tricuspid valve replacement need repair? JACC: Cardiovascular Imaging 2019 430–432. https://doi.org/10.1016/j.jcmg.2018.09.013)

    Google Scholar 

  20. Hahn RT & Zamorano JL. The need for a new tricuspid regurgitation grading scheme. European Heart Journal Cardiovascular Imaging 2017 1342–1343. https://doi.org/10.1093/ehjci/jex139)

    Google Scholar 

  21. Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, Dulgheru R, El Khoury G, Erba PA, Iung B, et al. 2015 ESC Guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). European Heart Journal 2015 3075–3128. https://doi.org/10.1093/eurheartj/ehv319)

    Google Scholar 

  22. San S, Ravis E, Tessonier L, Philip M, Cammilleri S, Lavagna F, Norscini G, Arregle F, Martel H, Oliver L, et al. Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in infective endocarditis. Journal of the American College of Cardiology 2019 1031–1040. https://doi.org/10.1016/j.jacc.2019.06.050)

    Google Scholar 

  23. Cahill TJ, Baddour LM, Habib G, Hoen B, Salaun E, Pettersson GB, Schäfers HJ & Prendergast BD. Challenges in infective endocarditis. Journal of the American College of Cardiology 2017 325–344. https://doi.org/10.1016/j.jacc.2016.10.066)

    Google Scholar 

Download references

Funding

This review did not receive any specific grant from any funding agency in the public, commercial or not-for-profit sector.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Erwan Donal MD PhD.

Additional information

This paper is part of a series on specialist valve clinics. The Guest Editors for this series were Richard P Steeds and John B Chambers

Rights and permissions

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.(http://creativecommons.org/licenses/by/4.0/), which permits use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Donal, E., Galli, E., Anselmi, A. et al. The central role of the cardiac imager in heart valve disease. Echo Res Pract 6, T15–T21 (2019). https://doi.org/10.1530/ERP-19-0046

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1530/ERP-19-0046

Key Words